Australia markets closed

ZIVO Bioscience, Inc. (9R8.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
3.21000.0000 (0.00%)
At close: 08:12PM CEST

ZIVO Bioscience, Inc.

21 East Long Lake Road
Suite 100
Bloomfield Hills, MI 48304
United States
(248) 452 9866
https://www.zivobioscience.com

Sector(s)
Industry
Full-time employees8

Key executives

NameTitlePayExercisedYear born
Mr. John B. PaynePresident, CEO & Chairman of the Board535.33kN/A1948
Mr. Keith R. MarchiandoCFO, Treasurer & Secretary338.82kN/A1962
Dr. Harlan L. Miller IIIVice President of Technology & Global SupplyN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

Corporate governance

ZIVO Bioscience, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.